Life Science Cares, an industry philanthropic organization, turns 10 in April. Now in five cities and Switzerland, the organization remains focused on fighting poverty.

Life sciences hubs beyond Boston and the Bay Area are giving startups new opportunities to grow and scale their businesses, ...

At a time of continuous change and increasing complexity, success for life sciences companies will largely depend on how they support, nurture and develop their teams. But even that has gotten more ...

Each January, the J.P. Morgan Healthcare Conference helps to set the biopharmaceutical industry agenda for the coming year, and more suits can be seen on the streets of San Francisco than during any ...

The “Bring your authentic self to work” mantra echoes incessantly around the corporate world. Everyone from executive coaches to New York Times bestselling books is saying that ‘authenticity’ is the ...

Here’s my thesis: biotech remains one of the most exciting and promising industries in the world, driven by the inescapable reality that nothing matters more than our health. Despite the fact that in ...

Royalty-bearing license agreements are a cornerstone of commercialization in the life sciences and technology industries. Companies often use them to expand their business into new markets while ...

Since the start of his second term, President Trump has shown a clear commitment to improving access to medicines for American patients. In late September 2025, his Administration reaffirmed this ...

Over the years, I’ve had the privilege of working alongside some extraordinary leaders. When I reflect on those who have left the most lasting impact on me, I often describe them as having what I call ...

As biotech companies face decreasing productivity, they need ways to do more with less, and fast. A fresh approach to achieve this is by rethinking how innovation is structured: collaborate early and ...

Biotechnology is all about scientific breakthroughs that lead to transformative therapies. But despite billions invested and years of R&D, data from Deloitte found that more than half of drug launches ...

As we find ourselves at the midpoint of the year, now is a perfect time to reflect on not only what has transpired thus far but more importantly what are some trends to focus on for the remainder of ...